Jeff Williams, Co-founder, President, and CEO of Clinipace Worldwide, a global full-service clinical research organization (CRO) he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of Chief Executive Officer. Williams will remain a Director and will focus on strategic initiatives on behalf of the Board of Directors.
“I am extremely proud of what we have built at Clinipace, but the time has come for me to replace myself and it is my pleasure to welcome Jason Monteleone as CEO,” said Jeff Williams. “After seeing him in action as a consultant to Clinipace over the last several months, I am confident he will build successfully on our company’s 14-year history and lead us into its next phase of growth.”
“I am honored to join Clinipace on the heels of the remarkable accomplishments that Jeff and his organization have achieved,” Monteleone said. “I am confident that the strong foundation he built, and the talented team here, will serve us well as we continue our quest to make Clinipace the leading mid-market CRO.”
Monteleone has over 20 years of experience in clinical research, life science, and healthcare-related organizations. He has also been Executive Vice President and Chief Financial Officer of Theorem Clinical Research, Chief Financial Officer of Omnicare Clinical Research, Senior Finance Director of MDS Pharma Services, and Finance Director at VIASYS Healthcare. He holds an MBA in Finance from the Fox School of Business and Management at Temple University and a BS in Business Administration from Millersville University of Pennsylvania.